ID

22676

Beskrivning

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Nyckelord

Versioner (1)

1. 2017-06-09 2017-06-09 -

Rättsinnehavare

Genentech, Inc.

Uppladdad den

9 juni 2017

DOI

För en begäran logga in.

Licens